Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds substantial non-obvious behavioral detail: the tool cascades through multiple endpoints internally, returns unresolved identifiers explicitly rather than omitting them, labels each identifier by source, and falls back to EDGAR identifiers when GLEIF/OpenFIGI are unavailable. None of this contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but the length is justified by the tool's complexity and edge cases. It front-loads the core purpose and 'FIRST' guidance, uses clear typographic markers for supported types, and organizes caveats like ambiguity and degradation. A few phrases are redundant (e.g., repeated identifier-labeling details), but no sentence is wasted.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining what the tool returns, and it does: canonical identifiers per type, source labels, figi_candidates for ambiguous matches, unresolved fields, and the RxNorm citation URI. It also covers non-obvious inputs like ISIN and difficult cases like non-equity instruments, making it actionable without needing external documentation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description goes beyond it: it gives ticker/CIK/name examples for company, brand/generic examples for drug, and a crucial usage caveat — pass only the entity name, never the full noun phrase, because trailing security-class words will match nothing. This materially helps an agent construct correct input.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and states a specific verb and resource: resolve a user-spoken NAME to canonical/official identifiers. It clearly distinguishes the tool from siblings by framing it as the first step before other tools that require IDs, and it explicitly enumerates supported entity types (company, drug).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit 'Use FIRST whenever you have a name but need an ID' directive, which tells an agent exactly when to invoke it. It also covers when results are ambiguous ('asserts nothing and returns figi_candidates') and notes graceful degradation when enrichment sources are unavailable, preventing misuse.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.3/5.0
Disambiguation4/5

Most tools have clearly distinct purposes, but the ask_pipeworx trio (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) and the polymarket cluster (arbitrage, edges, edge_tracker, fill_risk, kalshi_spread) could cause confusion without careful reading. However, the detailed descriptions effectively differentiate each tool's specific role.

Naming Consistency5/5

All tool names follow consistent snake_case convention with a verb-noun pattern (e.g., compare_entities, recent_changes, resolve_entity). There are no mixed conventions or chaotic naming, making the set predictable and easy to navigate.

Tool Count4/5

At 34 tools, the set is extensive but justified by the server's broad scope covering Vermont open data, Pipeworx data platform, prediction markets, and utility features. Each tool earns its place, though the count is slightly high compared to typical servers.

Completeness4/5

The tool surface covers data retrieval, entity analysis, prediction markets, memory, subscriptions, feedback, and claim validation. Minor gaps exist (e.g., no direct compliance tools), but the set is comprehensive for its stated purpose of data integration and analysis.